Today

EHang Holdings Ltd's FY 2025 revenue decreased 8.4% to RMB418.0 million, while net loss widened 20.2% to RMB276.4 million, and operating cash flow turned negative.

EHang Holdings is delaying its annual report to review revenue recognition policies, impacting the timing of certain revenue recognition.

INVO Fertility, Inc. saw Q1 2026 revenue jump 22.2% to $1.98 million and significantly narrowed its net loss by 68.2% to $(5.54) million, yet liquidity concerns persist.

INVO Fertility's 10-Q is delayed due to auditor transition and complex accounting reviews, impacting financial statement finalization.

iSpecimen Inc. reported a severe 85.25% drop in Q1 2026 revenue and a 37.20% increase in net loss, prompting a going concern warning due to recurring losses and negative working capital.

Apimeds Pharmaceuticals US, Inc.

WORK Medical Technology Group LTD's FY2025 revenue decreased 14.4% to $9.85 million, but the company significantly narrowed its net loss to $1.20 million and achieved positive operating cash flow of $6.24 million.

ZenaTech's 2025 revenue surged 558% to $12.9M, primarily from its new DaaS segment, but net loss expanded to $(45.2)M due to increased finance, wage, and G&A expenses, with negative operating cash flow.

Nebius Group N.V.

TeraWulf's Q1 2025 results show an 18.9% revenue decrease to $34.4 million and a widened net loss of $61.4 million, primarily due to increased power costs and bitcoin network difficulty, partially offset by strong operating cash flow.

Satellogic's Q1 2026 revenue surged 80.3% to $6.1 million, but net loss dramatically widened to $(118.3) million, primarily due to a non-cash fair value adjustment of financial instruments.

AST SpaceMobile reported a 28.4% increase in Q2 2025 revenue to $1.16 million, but net loss widened to $(99.39) million, primarily due to higher operating expenses and a significant loss on warrant liabilities.

Traws Pharma reported a net income of $9.2 million for FY2025, a significant turnaround from a $166.5 million net loss in FY2024, primarily due to a non-cash change in warrant liability....

Traws Pharma's 10-K filing is delayed due to ongoing financing efforts and substantial doubt about its ability to continue as a going concern.

Nocera, Inc. reported a 19.9% decrease in annual revenue to $13.6 million for FY2025, while narrowing its net loss by 35.8% to $(2.9) million....

Moleculin Biotech reported a widened net loss of $(33.56)M for FY2025, a 28.8% increase from the prior year. However, cash and cash equivalents surged 107.5% to $8.88M, extending the funding runway into Q3 2026....

Circle Internet Group's FY2025 revenue surged 63.9% to $2.75 billion, but the company posted a net loss of $69.5 million, a significant decline from the prior year's $155.7 million net income, largely due to...

Shopify reported a 30.1% increase in revenue to $11.56 billion and a 36.6% rise in operating income to $1.47 billion for FY2025....

Spotify Technology S.A. delivered strong financial results for fiscal year 2025, with revenue up 10.77% to €17.19 billion and net income surging 94.38% to €2.21 billion, driven by Premium subscriber growth.

NIO Inc. reported a 33.1% increase in revenues to RMB87.49 billion and a 33.3% reduction in net loss to RMB14.94 billion for FY2025, alongside a shift to positive operating cash flow.